RE:RE:RE:In normal market reaction the SP should have gone upMaxmoe wrote: PWIB123 wrote: They alienated and abandoned the investors who would have driven the price up today. The earnings report was actually really good. The share price is a reflection of the leadership team's past decisions. I do appreciate the turnaround in profitability, which should be enough to drive share price appreciation. Clearly there wasn't huge success in the patients that completed the TH-1902 trial. I'm guessing they'll have some parts and pieces that look good and have potential in combination therapy, but no standout results on their own. If there was, I think we would have heard about that today. I am pleased to hear them say there were no DLT's. That's a positive improvement.
My observation over the decades with this sector is "good news travels first class". It always leaks out. Mediocre results are delayed or buried. It was clearly not the blockbuster results we always hope for but too early to draw conclusions for me. Patience with the patients. Financial discipline is not a "given" for this sector, so it's a very good thing here.
And watch for the other shoe to drop. Not all shoes are a bad omen. When I see insider activity, that's my trigger to charge ahead and load up. Last month looks like it was a good entry point but I'd really like to see insider activity. Actual cash buying would be great but even just going into the trough shoulders deep to lock in options is a good sign. Let's see if we see anything post the quarterly blackout period.